As we pass through another stage of transition in the editorship of Toxicologic Pathology, we should pause to acknowledge the significant contributions of the outgoing Editor, Dr Carl L. Alden. As did his predecessors, Dr Alden created change in the Journal, amplifying its influence in toxicologic pathology. Over the past 4 years, Toxicologic Pathology has flourished and attained new dimensions under his leadership, commanding increased international attention. He introduced a broader, international flavor to its Editorial Board, and a formalized structure in the form of columns and sections. The dedicated work of the Associate, Section, and Column Editors that he appointed has substantially contributed to the international presence of the Journal. Dr Alden has envisioned toxicologic pathology as a broad-based discipline, the influence of which extends out of the laboratory into the environment and, indeed, into the homes of every person around the world. In other words, he recognized that the scope of toxicologic pathology went beyond a consideration of commercially manufactured chemicals to include naturally occurring and other chemicals that have an effect on the environment and its fauna or flora. It has always been Dr Alden's vision that the pathologist is well equipped to master and apply emerging technologies and consequently will participate substantially in the solving of problems related to xenobiotics in the environment. Also, he believes pathologists will be a growing force in progressing the efficiency of discovery and development of new molecules, which inevitably will lead to significant improvement in the quality of life for all living creatures in the new millennium. The ability of the toxicologic pathologist to refine risk assessment through appli-
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We owe Dr Alden a debt of gratitude for his contributions and eminence in our profession. We will continue to seek his guidance as he steps down from Editor to assume the role of Deputy Editor. We also wish to express sincere appreciation to Jill Young, Assistant Editor from 1996 into 1999, for her commitment to the growing success of the Journal.
The mandate for the Editor-in-Chief of Toxicologic Pathology is to position the Journal as the world's leading medium for reporting research, reviews, and commentaries in this broadening discipline. The strategic focus for a new Editor should be directed toward enhancing the Journal's sphere of influence and improving the quality of the contents to the next level, thereby expanding overall interest in the Journal and acting in turn as a stimulus for new subscriptions and new membership to the Society.
The Journal will continue to solicit and publish high quality reports on safety evaluation and mechanisms of action of chemicals and substances, as well as innovative research and diagnostic aspects relating to the broadened scope of toxicologic pathology. However, with succession of editorship, inevitably come some changes. It is my perception that the boundary between safety assessment and investigative pathology has become less distinct in recent years. This is because assessment of the safety of new chemicals no longer relies on the conventional acute, subchronic, and chronic toxicity tests, but more and more has been incorporating an investigative approach to elucidate aspects of mechanisms of action. Perhaps this is a natural course in response to regulatory authorities being more receptive to considering mechanistic data in order to improve the risk assessment process. As a consequence, I am amalgamating the sections of &dquo;Safety As-sessment&dquo; and &dquo;Investigative Pathology&dquo; under a term of broader meaning: &dquo;Safety Evaluation.&dquo; Using this heading there will be 3 separate sections accounting for 3 separate categories of chemicals and substances, namely &dquo;Safety Evaluation-Pharmaceuticals,&dquo; &dquo;Safety Evaluation-Food and Chemicals,&dquo; and &dquo;Safety Evaluation-Agrochemicals.&dquo; Such categorization may introduce some additional order into the Journal's contents.
In addition, there has been a trend for some pathologists to move away from traditional safety evaluation into pharmaceutical discovery. Accordingly, there has been increasing interest from a sector of the Society membership in extending the Journal's scope into an area that some refer to as discovery pathology. The vision is that such a section could attract manuscripts that deal with characterization of animal models of efficacy, identification of therapeutic cellular targets, and improvement of the sensitivity of efficacy assessment and thus efficiency of the discovery process in general. To this end, a new section has been included that I have entitled &dquo;Product Discovery&dquo; because it will not necessarily be limited to therapeutic agents. Broadening the scope of the Journal in this way may attract new membership currently situated on the fringe of toxicologic pathology. If this happens, it is to be hoped that such specialists in the field of discovery are welcomed into the ranks of the Society.
It is recognized that laboratory animal pathology has encompassed new dimensions with the advent of transgenic and knockout rodents. Accordingly, the title of this section has been extended to &dquo;Laboratory Animal and Molecular Pathology.&dquo; The section, &dquo;Environmental Pathology,&dquo; will continue to be a repository for studies that describe the effects of chemicals or substances that impact the environment or, conversely, environmental exposures representing a hazard for human health.
Many of the Editorial Board and special Editors will remain the same, but there are new names. The key to maintaining a high quality of scientific product in the Journal is having access to reviewers that are knowledgeable in the topic of the submission and who are prepared to provide a thoughtful, objective, and insightful critique of each submitted manuscript. Thus, the individuals chosen for the editorial structure not only cover a wide range of expert knowledge but have also stated a willingness to be working members prepared to review manuscripts, promote the Journal amongst colleagues, and, if asked, recommend suitable referees for specific topics. In this respect, the Journal's Editor has always been fortunate in having an enthusiastic constituency of Society members who appear eager to contribute to, and support, the manuscript review process.
Because of the significant efforts of Dr Andrew Fix and his XVIII International Symposium Program Committee, the first issue in my editorial term is an outstanding contribution to the discipline of toxicologic pathology. With their scientific program on neurotoxicology, Dr Fix and his team ensured a first class meeting with record-breaking attendance for the Society. That high quality is reflected in the Symposium papers submitted for publication in the Journal. This issue brings us up-todate with state-of-the-art knowledge on structure and function in neurobiology, cutting-edge technology in identifying neurotoxic effects, and mechanistic approaches to understanding neurotoxicity and exploring neurotoxic injury. Also, this outstanding collection of papers appropriately represents the first issue of the new century and of the new millennium.
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